Literature DB >> 9184747

Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features.

J M Schierholz1, H Steinhauser, A F Rump, R Berkels, G Pulverer.   

Abstract

Polymer-associated infections are of increasing importance. Antistaphylococcal antimicrobial substances (ciprofloxacin, gentamycin, fosfomycin, flucloxacillin) were incorporated into polyurethanes by the solvent casting technique. Drug release rates, bacterial colonization and morphological features were evaluated to predict and understand the antimicrobial activity of these delivery systems. Drug release characteristics were investigated by standard bioassay and high-performance liquid chromatography (HPLC), and the physico-chemical mechanisms of the delivery were discussed. Ciprofloxacin hydrochloride showed a fast initial release rate, whereas gentamicin-base was characterized by a more continuous release type of behaviour. Bacterial colonization to the antibiotic-loaded polyurethanes was inhibited effectively by preparations showing a slower but more sustained antimicrobial delivery. Polyurethane-antibiotic combinations were most homogeneous for gentamicin-base and flucloxacillin as shown by scanning electron microscopy (SEM). In polymers loaded with fosfomycin and ciprofloxacin a granular structure of the crystallized drug embedded in the polyurethane matrix could be demonstrated. Physico-chemical similarity of the polymeric material and the antibiotics is important for the homogeneity of polymer-antibiotic combinations. High homogeneity is required for a sustained and prolonged release over time and effective inhibition of bacterial colonization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184747     DOI: 10.1016/s0142-9612(96)00199-8

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  19 in total

Review 1.  [Special aspects of implant-associated infection in orthopedic surgery. From the pathophysiology to custom-tailored prevention strategies].

Authors:  J M Schierholz; C Morsczeck; N Brenner; D P König; N Yücel; M Korenkov; E Neugebauer; A F E Rump; G Waalenkamp; J Beuth; G Pulverer; S Arens
Journal:  Orthopade       Date:  2004-04       Impact factor: 1.087

Review 2.  Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems.

Authors:  Yao Fu; Weiyuan John Kao
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

3.  Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics.

Authors:  John C Carmen; Beverly L Roeder; Jared L Nelson; Rachel L Robison Ogilvie; Richard A Robison; G Bruce Schaalje; William G Pitt
Journal:  Am J Infect Control       Date:  2005-03       Impact factor: 2.918

4.  Sustained release of antibiotic from polyurethane coated implant materials.

Authors:  Piyali Basak; Basudam Adhikari; Indranil Banerjee; Tapas K Maiti
Journal:  J Mater Sci Mater Med       Date:  2008-07-18       Impact factor: 3.896

5.  Biocidal efficacy, biofilm-controlling function, and controlled release effect of chloromelamine-based bioresponsive fibrous materials.

Authors:  Zhaobin Chen; Jie Luo; Yuyu Sun
Journal:  Biomaterials       Date:  2006-12-20       Impact factor: 12.479

6.  Nitric oxide-flux dependent bacterial adhesion and viability at fibrinogen-coated surfaces.

Authors:  Scott P Nichols; Mark H Schoenfisch
Journal:  Biomater Sci       Date:  2013-11-01       Impact factor: 6.843

7.  Effect of pulsed ultrasound in combination with gentamicin on bacterial viability in biofilms on bone cements in vivo.

Authors:  G T Ensing; B L Roeder; J L Nelson; J R van Horn; H C van der Mei; H J Busscher; W G Pitt
Journal:  J Appl Microbiol       Date:  2005       Impact factor: 3.772

8.  Inhibition of Candida albicans biofilm formation by antimycotics released from modified polydimethyl siloxane.

Authors:  Kristof De Prijck; Nele De Smet; Kris Honraet; Steven Christiaen; Tom Coenye; Etienne Schacht; Hans J Nelis
Journal:  Mycopathologia       Date:  2009-09-23       Impact factor: 2.574

Review 9.  Beyond conventional antibiotics - New directions for combination products to combat biofilm.

Authors:  Danir Fanisovich Bayramov; Jennifer Ann Neff
Journal:  Adv Drug Deliv Rev       Date:  2016-08-03       Impact factor: 15.470

10.  Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.

Authors:  Julie A Wu; Caroline Kusuma; James J Mond; John F Kokai-Kun
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.